NZ drug subsidy agency must look beyond statin prices Newsletter Article 11 February 2013 Pages: 3 - 3
DM programme promotes guidelines to reduce asthma events and costs Newsletter Article 11 February 2013 Pages: 4 - 4
Discontinuing or switching antihypertensive agents is costly Newsletter Article 11 February 2013 Pages: 5 - 5
Breakdown of rheumatoid arthritis costs in The Netherlands Newsletter Article 11 February 2013 Pages: 5 - 5
Value of tocopherol in preventing MI supported by CHAOS substudy Newsletter Article 11 February 2013 Pages: 5 - 5
Valuing strategies for preventing vertical HIV transmission Newsletter Article 11 February 2013 Pages: 6 - 6
Clozapine reduces healthcare service use at minimal cost Newsletter Article 11 February 2013 Pages: 6 - 6
Pharmacist counselling for smoking cessation cost effective? Newsletter Article 11 February 2013 Pages: 7 - 7
Tight BP control ‘good value’ in diabetics with hypertension Newsletter Article 11 February 2013 Pages: 7 - 7
MK-966 improves physical functioning in osteoarthritis Newsletter Article 11 February 2013 Pages: 10 - 10
More Alzheimer’s research needed as epidemic looms Newsletter Article 11 February 2013 Pages: 10 - 10
New asthma/COPD programme aims to reduce ‘grim statistics’ Newsletter Article 11 February 2013 Pages: 11 - 11